Hematology, Neurology Star in Swan Song for the Office of New Drugs' Division Structure

Hematology, Neurology Star in Swan Song for the Office of New Drugs' Division Structure
Executive Summary Pink Sheet analysis of three years of novel US FDA approvals show the swiftest average time to approval in oncology, hematology, and antiviral divisions; neurology and hematology divisions contributed the most approvals.

Executive Summary

Pink Sheet analysis of three years of novel US FDA approvals show the swiftest average time to approval in oncology, hematology, and antiviral divisions; neurology and hematology divisions contributed the most approvals.

Source: pink.pharmamedtechbi.com